Immunotherapy Committee (ITH)

The ITH Committee has been created to assist in the development and clinical application of immunotherapy in the treatment of cancer and infectious diseases with special emphasis on the developing world.

What is the ITH?

The IUIS Immunotherapy Committee (ITH) has been created to assist in the development and clinical application of immunotherapy in the treatment of cancer and infectious diseases with special emphasis on the developing world. 

Remit includes:
  1. Develop policy positions on the application of new immune therapy approaches in cancer and infectious diseases
  2. Communication with other organizations devoted the supporting immunotherapy (i.e. SITC; joint projects)
  3. Sponsor public and academic education on immune therapy issues

Resources

Listen to a BBC5 radio interview on T-cell related discoveries:
http://www.thenakedscientists.com/HTML/specials/show/20160224/

Resources

#ThankYouImmunology video campaign for the 2022 Day of Immunology

The 2022 #ThankYouImmunology campaign will play out on social media on the four days leading…


Back to Committees

More Committees

Veterinary Immunology Committee (VIC)

Vaccine Committee (VAC)

Quality Assessment and Standardization Committee (QAS)

Publications Committee (PUB)

Nomenclature Committee (NOM)

Inborn Errors of Immunity Committee (IEI)

Gender Equality Committee (GEC)

Education Committee (EDU)

Clinical Immunology Committee (CIC)